🇺🇸 FDA
Patent

US 8163917

Azaindoles useful as inhibitors of Janus kinases

granted A61KA61K31/506A61K31/517

Quick answer

US patent 8163917 (Azaindoles useful as inhibitors of Janus kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
58
CPC classes
A61K, A61K31/506, A61K31/517, A61K31/53, A61K31/5377